TRVI
Trevi Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -4.3% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | 0 | 67.23M | $1.24B | +8 | −8 |
| Q1 2026 | 77 | +2 | 59.43M | $710.63M | +8 | −6 |
| Q4 2025 | 75 | 0 | 58.45M | $731.74M | +1 | −1 |
| Q3 2025 | 18 | 0 | 44.17M | $404.20M | — | — |
| Q2 2025 | 15 | 0 | 25.58M | $139.93M | +1 | −1 |
| Q1 2025 | 12 | 0 | 12.85M | $80.81M | +1 | −1 |
| Q4 2024 | 12 | +4 | 15.26M | $62.88M | +4 | — |
| Q3 2024 | 7 | +3 | 5.91M | $19.73M | +3 | — |
| Q2 2024 | 4 | — | 5.62M | $16.74M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 8.21M | — | $44.88M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 5.32M | — | $29.08M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 5.32M | — | $29.08M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passief) | 5.32M | — | $29.08M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 2.48M | -3.0% | $13.55M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Marshall Wace ✦ | 2.48M | -3.0% | $13.55M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (passief) | 1.83M | +28.7% | $10.03M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passief) | 1.79M | +10.7% | $9.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passief) | 1.79M | +10.7% | $9.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 1.73M | -27.0% | $9.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Viking Global Investors ✦ | 1.54M | -52.2% | $8.44M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 1.32M | Nieuw | $7.22M | 0.0% | New | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 489.30K | +450.4% | $2.68M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 368.53K | — | $2.02M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 368.53K | — | $2.02M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Wellington Management ✦ | 171.98K | +34.9% | $940,742 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Wellington Management ✦ | 171.98K | +34.9% | $940,742 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Wellington Management ✦ | 171.98K | +34.9% | $940,742 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | Millennium Management ✦ | 157.24K | -80.9% | $860,125 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 29 | Two Sigma Investments ✦ | 120.24K | +2.1% | $657,713 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 38.55K | +19.9% | $211,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 24.83K | -10.4% | $135,821 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 24.83K | -10.4% | $135,821 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 24.83K | -10.4% | $135,821 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $7.22M | 0.0% |
Verlaten
| Adage Capital Partners | $2.77M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 198 houders, 134.86M aandelen, $1.61B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.